Juergen Schmider MD, PhD

Juergen Schmider M.D., Ph.D. is a trained psychiatrist and clinical pharmacologist with 10 years of academic research and 19 years of pharmaceutical industry experience. His research during his academic years included the neuroendocrinology of the hypophysis-pituitary-adrenal system at the Max Planck Institute, Munich, Germany as well as CYP mediated metabolism of psychoactive drugs at Tufts University Boston and Humboldt University Berlin.
His industry experience led him from positions with increasing responsibility from Pfizer (Therapeutic Area Safety Head), Johnson & Johnson (VP Benefit Risk Management), Cephalon (Chief Safety Officer), Sanofi (VP Safety Surveillance and Risk Management), VP and Head of Global Product Safety at Hospria, and most recently VP, head of Safety Evaluation and Reporting in Worldwide Safety, Pfizer.